New link discovered between class of rogue autoantibodies and poor health outcomes

December 06, 2016

Results of a new study led by Johns Hopkins researchers offer new evidence for a strong link between angiotensin receptor autoantibodies and increased risk of frailty. In a report on the work, published online in the journal Circulation on Nov. 30, the team says a large class of common blood pressure drugs that target the angiotensin receptor, called angiotensin receptor blockers (ARBs), may help patients depending on the levels of the autoantibodies.

In healthy individuals, immune cells produce proteins called antibodies that attack foreign invaders to destroy them and clear them out of the system. In contrast, with autoimmune disorders, the immune cells produce autoantibodies that target the body's own tissue.

"We discovered that frail older individuals have markedly higher levels of an autoantibody against its own angiotensin system. The angiotensin system is a key hormonal system that regulates blood pressure and fluid balance. The presence of these antibodies in this subset of vulnerable older adults was associated with increased inflammatory burden, and with decline in grip strength, walking speed and increased number of falls," says Neal Fedarko, Ph.D., professor of medicine and co-director of the Biology of Healthy Aging Program at the Johns Hopkins University School of Medicine, and the paper's senior author.

Individuals with higher levels of autoantibodies were also more likely to suffer from higher blood pressure. The use of ARBs in such individuals correlated with better control of their blood pressure, suggesting a possible personalized medicine approach to high blood pressure treatment in older adults.

Elevated levels of these autoantibodies have long been linked to autoimmune disorders, such as malignant hypertension, transplant rejection and pre-eclampsia, a pregnancy complication marked by high blood pressure. The cause of elevated autoantibodies, however, has been elusive.

Some older adults become frail as they age, and this frailty has been associated with chronic inflammation. To examine the relationship between autoantibody levels and frailty, the research team first recruited 255 participants ages 20 to 93 in Baltimore, Maryland. Participants were separated into two categories: 169 younger adults (ages 20 to 69) and 87 older adults (70 and older).

The team measured blood levels of autoantibodies and found that older adults had nearly twice the levels of autoantibodies than the younger adults -- a median of 7.3 micrograms per milliliter of blood compared to the younger adult group's median level of 3.76.

The researchers then used a frailty screening tool to identify frail older adults by measuring grip strength and walking speed, and asking questions about weight loss, fatigue and levels of physical activity. Older adults with high autoantibody levels were 3.9 times more likely to be frail.

For every 1 microgram per milliliter of blood increase in autoantibodies, the researchers observed a decrease in hand grip strength of 5.7 pounds. Additionally, every 1 microgram per milliliter of blood increase in autoantibodies increased the odds of falling by 30 percent.

"What makes our findings significant is that these autoantibodies, which are a good predictor of frailty, are also a known mechanism for promoting chronic inflammation, which underlies a number of diseases and pathologies, especially aging-related conditions," says Fedarko.

"Building off of our knowledge that these autoantibodies cause chronic inflammation, we decided to look at a class of medications, angiotensin receptor blockers, that block inflammation and are commonly prescribed to lower blood pressure," says Peter M. Abadir, M.D., associate professor of medicine at the Johns Hopkins University School of Medicine and the paper's lead author.

Approximately 70 million adults -- every one in three -- in the U.S. suffer from high blood pressure. The most commonly prescribed ARBs include candesartan, eprosartan, irbesartan and losartan.

To examine the effects of autoantibodies levels on ARBs, Abadir and his team collected 20-year-old data from a second patient population in Chicago and measured patients' previously collected serum for autoantibody levels. The 60 participants were 70 to 90 years old, and half had been treated with ARBs.

The researchers observed similar associations between autoantibody levels and decline in grip strength and walking speed in the Chicago population. Furthermore, for every 1 microgram per milliliter increase of autoantibodies, those not receiving ARBs lived 115 days less -- approximately shortened life span by 9 percent. Chronic treatment with ARBs attenuated the autoantibodies' association with decline in grip strength and increased mortality.

Abadir notes that this study is the first to examine the associations between the autoantibodies with demographic, physiological and functional outcomes. The authors caution, however, that the findings do not prove cause and effect, and do not suggest that patients alter blood pressure treatment without consulting their physician first.

Current clinical practice is to prescribe ARBs as a first-line drug to many patients with high blood pressure, and physicians should now be more aware of potential role for these autoantibodies in decision to treat.

"ARBs are great for some people but don't work for others. Because people respond to them differently, the goal is to identify who we should treat and who we shouldn't. We've discovered that autoantibodies may help us identify which population benefits most from ARB treatment," explains Fedarko.
-end-
Other authors on this paper include Alka Jain, Laura J. Powell, Qian-Li Xue, Jing Tian, Robert G. Hamilton, Thomas Finucane and Jeremy D. Walston from The Johns Hopkins University, and David A. Bennett from Rush University Medical Center.

Funding for this study was provided by the U.S. Department of Defense (W81XWH-11-1-0239), the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR 001079), the National Cancer Institute of the National Institutes of Health (1R01CA149273), the National Institute on Aging of the National Institutes of Health (K23 AG035005 and P30 AG021334) and the Nathan W. and Margaret T. Shock Aging Research Foundation

Johns Hopkins Medicine

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.